Study on obtaining bacterial cellulose by Komagataeibacter xylinus in co-culture with lactic acid bacteria in whey
Applied Microbiology and Biotechnology · 21.08.2025 · 109 (1)
DOI: 10.1007/s00253-025-13582-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 21.08.2025. Verfasst von Justyna Płoska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Technology and Assessment, Institute of Food Sciences, Warsaw University of Life Sciences - SGGW, Nowoursynowska Street 166, 02-78…. Hauptthemen laut MEDLINE: Cellulose, Whey, Lactobacillales, Gluconacetobacter xylinus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowa Agencja Wymiany Akademickiej, Ministerstwo Edukacji i Nauki.
Abstract (Originalsprache)
The use of acid whey as a medium is an innovative approach to bacterial cellulose (BC) biosynthesis in co-cultures of acetic acid bacteria with lactic acid bacteria. The aim of this study was to evaluate the possibility of obtaining BC in acid whey by co-culturing K. xylinus with selected strains of lactic acid bacteria and comparing the properties of this biopolymer with BC obtained in K. xylinus monoculture. The K. xylinus + Lb. acidophilus co-culture yielded 2.19 g·L −1 of BC, which was 125% more than the K. xylinus monoculture. Additionally, K. xylinus in co-culture with Lb. acidophilus increased the degradation temperature of BC to 361 °C compared to 303 °C for BC obtained in monoculture. The BC obtained in the co-cultures showed better mechanical properties. BC obtained in co-culture with Lb. delbrueckii showed more than twice the Young’s modulus than BC from monoculture. Moreover, strain at break BC from co-culture with Lb. acidophilus and stress at break BC from co-culture with Lb. helveticus were 72% and 54% higher, respectively, than BC obtained from monoculture K. xylinus. In this study, it was shown that conducting acetic-lactic co-cultures increased the efficiency of BC biosynthesis and improved its properties. Moreover, this study has shown that acid whey is a sufficient and complete substrate for obtaining BC. Results presented in this paper indicate new possibilities for the management of this side product. Key points • The K. xylinus + Lb. acidophilus co-culture produced 125% more cellulose than the monoculture. • High lactic acid content and low pH of acid whey enhance cellulose biosynthesis. • Acetic acid-lactic acid co-cultures improved the mechanical properties of cellulose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Technology and Assessment, Institute of Food Sciences, Warsaw University of Life Sciences - SGGW, Nowoursynowska Street 166, 02-787, Warsaw, Poland. justyna_ploska@sggw.edu.pl.
- Department of Food Technology and Assessment, Institute of Food Sciences, Warsaw University of Life Sciences - SGGW, Nowoursynowska Street 166, 02-787, Warsaw, Poland.
Förderung
- Narodowa Agencja Wymiany Akademickiej
- Ministerstwo Edukacji i Nauki
Zitieren
APA
Płoska, J., Garbowska, M., Ścibisz, I., & Stasiak-Różańska, L. (2025). Study on obtaining bacterial cellulose by Komagataeibacter xylinus in co-culture with lactic acid bacteria in whey. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13582-3
Vancouver
Płoska J, Garbowska M, Ścibisz I, Stasiak-Różańska L. Study on obtaining bacterial cellulose by Komagataeibacter xylinus in co-culture with lactic acid bacteria in whey. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13582-3
BibTeX
@article{Poska2025,
author = {Płoska, Justyna and Garbowska, Monika and Ścibisz, Iwona and Stasiak-Różańska, Lidia},
title = {Study on obtaining bacterial cellulose by Komagataeibacter xylinus in co-culture with lactic acid bacteria in whey},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13582-3}
}
EUVIMED